Atherectomy Devices Market - Global Forecasts to 2022

Atherectomy Devices Market by Type (Hydrodynamic, Ultrasound, Aspiration, Mechanical Thrombectomy), Application (Cardiovascular, Peripheral, Neurovascular), End User (Hospitals, Surgical Centers, Ambulatory, Academia, CROs) - Global Forecasts to 2022

​Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market.

The report studies the global Atherectomy Devices Market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. 
Browse 77 Market Data Tables and 47 Figures spread through 149 Pages and in-depth TOC on "Atherectomy Devices Market"
http://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html
Early buyers will receive 10% customization on this report 

Based on product, the directional atherectomy devices segment is expected to witness the highest growth during the forecast period. 

On the basis of product, the Atherectomy Devices Market is categorized into directional, orbital, photo-ablative (laser), rotational atherectomy devices, and support devices. In 2017, the directional atherectomy devices segment accounted for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to clinical benefits offered (such as lack of barotrauma, less risk of neointimal hyperplasia, immediate change of bypass site, and availability of differently sized instruments to enable atherectomy in blood vessels) and ongoing technological advancements in the field of directional atherectomy.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=133112140
Based on application, the peripheral vascular applications segment is estimated to have the largest share of the market in 2017. 

Based on application, the market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the major share of the market owing to the significant availability of clinical evidence to support the therapeutic efficacy of atherectomy in PVD treatment and growing patient preference for minimally invasive surgical procedures.

Based on end user, the hospitals and surgical centers segment is expected to witness the highest growth during the forecast period. 

Based on end user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment is expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=133112140

North America is expected to dominate the Atherectomy Devices Market in 2017. 

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American Atherectomy Devices Market. 

However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Major players operating in the Atherectomy Devices Market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Healthcare Business Intelligence Market Size, Industry Growth , Opportunities and Forecast to 2023

"Healthcare Business Intelligence Market by Component (Platform, Software, Service), Function (OLAP, Performance Management), Application (RCM, Inventory, Strategy Analysis), Deployment Model (Cloud, Hybrid) & End User (Payer, Hospital) - Forecast to 2023", published by MarketsandMarkets™, the Healthcare Business Intelligence Market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3% during the forecast period.

Don't miss out on business opportunities in Healthcare Business Intelligence Market

Speak to Our Analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=252368925
The growth of this market is mainly driven by the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries.

Clinical analysis segment is expected to grow at the highest CAGR in the Healthcare Business Intelligence Marketduring the forecast period. 

Based on the application, the Healthcare Business Intelligence Market is segmented into clinical analysis, financial analysis, and operational analysis. In 2018, the clinical analysis segment is expected to grow at the highest CAGR during the forecast period market, primarily due to the growing pressure to curtail healthcare spending, increasing government incentives (especially in the US) for improving the quality and reducing the cost of care, growing adoption of EHRs, and rising focus on building patient registries.

Browse in-depth TOC on "Healthcare Business Intelligence Market"
150 - Tables 
40 - Figures  
194 - Pages  

View more detailed TOC @  
https://www.marketsandmarkets.com/Market-Reports/healthcare-business-intelligence-market-252368925.html
Growing demand for cloud-based healthcare BI solutions is driving the growth of this segment

On the basis of deployment model, the Healthcare Business Intelligence Market is segmented into on-premise, hybrid, and cloud-based models. In 2018, cloud-based models are expected to register the highest CAGR during the forecast period. Factors such as on-demand self-serving analytics, their highly adaptable nature, ease of use, affordability, reliability, no upfront capital investment for hardware, extreme capacity flexibility, and a pay-as-you-go pricing model is expected to boost the demand for healthcare business intelligence services.

North America is expected to lead the Healthcare Business Intelligence Market in 2023 

On the basis of the region, the Healthcare Business Intelligence Market is segmented into North America, Europe, Asia, and the RoW. In 2018, North America is expected to account for the largest share of the market, followed by Europe, The largest share of the North American market is attributed to the factors such as The increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs. In 2018, Europe is expected to hold the second-largest share. Factors such as the need to provide quality healthcare quicker and efficiently rises, it will drive the adoption of tools to streamline healthcare delivery; this will prove favorable to the growth of the Healthcare Business Intelligence Market in Europe.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=252368925
The Healthcare Business Intelligence Market is highly competitive, with the presence of both large and small players. Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland) are some of the leading payers in Healthcare Business Intelligence Market.

Browse Adjacent Markets @ Healthcare IT Market Research Reports & Consulting
About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. 

MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Parkinson's Disease Treatment Market 2018- Industry Growth, Size , Share, Analysis and Global Forecast to 2022

"Parkinson's Disease Treatment Market by Drug Class (Carbidopa/Levodopa, Dopamine Receptor Agonists, MAO-Inhibitors), Distribution Channel (Hospital, Online, Retail Pharmacies), Patient Care Setting (Hospitals, Clinics) - Global Forecast to 2022"

The Parkinsons disease treatment market is expected to reach USD 5.69 Billion by 2022 from USD 4.24 Billion in 2017, at a CAGR of 6.1%.

The market is being driven by the growth in aging population and the associated increase in the prevalence of Parkinsons disease and government funding for research.

Browse 66 Market Data Tables

33 Figures 

113 Pages and in-depth TOC on "Parkinson's Disease Treatment Market
https://www.marketsandmarkets.com/Market-Reports/parkinson-disease-treatment-market-47265247.html
Early buyers will receive 10% customization on reports.

By drug class, the carbidopa/levodopa segment is estimated to dominate the market in 2017

On the basis of drug class, the Parkinson’s disease therapeutic drugs market is segmented into carbidopa/levodopa, dopamine receptor agonists, MAO inhibitors, COMT inhibitors, anticholinergics, and other drugs. In 2017, the carbidopa/levodopa segment is expected to account for the largest share of the market. Carbidopa/levodopa drugs are more potent than most other drug classes are hence widely used in the treatment of Parkinson’s disease.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=47265247

By distribution channel, the hospital pharmacies segment is estimated to hold the largest share of the market in 2017

By distribution channel, the Parkinson’s disease therapeutic drugs market has been segmented into hospital pharmacies, retailer pharmacies, and online pharmacies. In 2017, the hospital pharmacies segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to the availability of a wide range of drugs in these facilities and the increasing number of patient visits to hospitals.

Hospitals to dominate the Parkinsons disease treatment market during the forecast period

The Parkinsons disease treatment market is classified by patient care settings into hospitals and clinics. In 2017, the hospital segment is expected to command the largest share and is estimated to grow at the fastest rate as compared to clinics segment. This market is mainly driven by robust healthcare services provided in hospitals and the presence of skilled neurologists in the hospitals.

Asia to offer lucrative growth opportunities

By region, the global Parkinsons disease treatment market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While Europe is expected to hold the largest share of the market in 2017, Asia is expected to grow at the highest CAGR during the forecast period. Increasing number of players in the region and the rising aging population are some major factors driving the high growth of this regional segment.

Some of the major players operating in the Parkinson’s disease treatment market include Teva (Israel), Novartis AG (Switzerland), GSK (UK), AbbVie (US), Merck (US), Boehringer Ingelheim (Germany),  Impax Laboratories (US), Lundbeck (Denmark), Sun Pharma (India), Wockhardt (India), UCB (Belgium), Valeant Pharmaceuticals (Canada), and Acadia (US).

Speak To Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=47265247

Target Audience:

• Parkinson’s disease treatment product manufacturers
• Parkinson’s disease treatment dealers and suppliers
• Human identification service providers
• Parkinson’s disease associations
• Academic institutions
• Venture capitalists
• Consulting firms
• Government bodies

Surgical Staplers Market Size, Industry Growth,Share and End User- Global Forecast to 2022

Surgical Staplers Market is expected to reach USD 4.78 Billion by 2022 from USD 3.38 Billion in 2017, at a CAGR of 7.2 %.

Browse 109 market data tables 

and 37 figures 

 183 pages and in-depth TOC on "Surgical Staplers Market"

http://www.marketsandmarkets.com/Market-Reports/surgical-stapler-market-79557149.html

Early buyers will receive 10% customization on this report 

The growth of the market is attributed to the increasing number of surgical procedures across the globe, growing preference for minimally invasive surgeries, technological advancements, and increasing preference for surgical staplers over sutures. The growing popularity of cosmetic surgeries, medical tourism in developing economies, increasing healthcare demand in low- and middle-income countries is expected to offer lucrative growth opportunities for players in the Surgical Staplers Market.

Manual surgical staplers to dominate the market in 2017 

Based on product, the market is segmented into manual surgical stapler and powered surgical stapler. The manual surgical stapler segment is expected to account for the largest share of the surgical stapler market in 2017. Manual surgical staplers are faster, more economical, and cause fewer infections than stitches. It also causes low tissue reactivity, which helps in preventing SSIs as compared to conventional methods available for wound closure such as sutures.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=79557149

On the basis of end user, hospitals are to grow at the highest CAGR within the forecast period 

By end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs) & clinics. In 2017, this segment is also expected to register the highest CAGR during the forecast period. Rapidly increasing patient volume, the subsequent increase in the number of complex surgeries, easy accessibility to multiple specialty treatments in a single facility, and favorable reimbursements is expected to drive the demand for surgical staplers among hospitals.

North America to dominate the market followed by Europe 

By region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2017, North Americaaccounted for the largest share of the market; Asia-Pacific is expected to register the highest CAGR during the forecasted period, followed by Europe.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=79557149

North America dominated the market in 2016 

The high growth of the Asia-Pacific market is attributed to the factors such as increasing per capita income levels (and consequent increase in purchasing power), growing healthcare awareness, rising number of private sector hospitals, development of primary healthcare infrastructure, and growing medical tourism in this region. Europe is the second largest growing market; factors such as growing number of surgical procedures and increasing preference for bariatric and cosmetic surgeries are expected to fuel the market growth in this region.

The Surgical Staplers Market is duopolistic in nature with two major players Ethicon Inc. (U.S.) and Medtronic plc (Ireland). CONMED Corporation (U.S.), Smith & Nephew (U.K.), Purple Surgical Inc. (U.K.), Intuitive Surgical Inc. (U.S.), Welfare Medical Ltd. (U.K.), Reach surgical Inc. (China), Meril Life Science Pvt. Ltd. (India), Grena Ltd. (U.K.), B. Braun Melsungen AG (Germany), Dextera Surgical Inc. (U.S.), Frankenman International (China), and Becton, Dickinson and Company (U.S.) are some of the other players operating in the global Surgical Staplers Market.

Surgical Lasers Market by product type- Global forecast to 2021

This report studies the global market over the forecast period of 2016 to 2021. The market is expected to reach USD 2.37 Billion by 2021; growing at a CAGR of 5.1% from 2016 to 2021.

Surgical Lasers Market by Product Type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021", published by MarketsandMarkets,

Browse 75 market data Tables
55 Figures spread through
166 Pages and in-depth TOC on"Surgical Lasers Market"

http://www.marketsandmarkets.com/Market-Reports/surgical-laser-market-12712582.html
Early buyers will receive 10% customization on this report.

Factors driving the growth of this market include technological advancements in surgical lasers, high prevalence of chronic diseases, high prevalence of ophthalmic disorders, and growing preference for minimally invasive surgeries. However, limited medical reimbursements and high procedural costs associated with laser surgeries are expected to limit the optimal growth of this market during the coming years.

On the basis of type, the Surgical Lasers Market is categorized into five segments, namely, carbon dioxide (CO2) lasers, argon lasers, Nd:YAG lasers, diode lasers, and other surgical lasers (fiber lasers, dye lasers, Er:YAG lasers, and excimer lasers). The carbon dioxide (CO2) lasers segment is growing at the highest CAGR in the market due to the widespread availability of innovative CO2-based surgical lasers and ongoing technological advancements in cosmetic laser treatment.

Speak To Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=12712582

Based on procedure type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery. The laparoscopic surgery segment is expected to dominate the market. This growth can be primarily attributed to the procedural benefits of laparoscopic procedures and growing patient awareness and market demand for less-invasive disease therapies.

By application, the market is segmented into ophthalmology, dentistry, dermatology, cardiology, gynecology, urology, oncology, and other applications (liposuction, ENT, and GIT). The urology segment is expected to be the fastest-growing surgical laser application segment. Growth in this application segment can be attributed to the rising prevalence of urological disorders (such as kidney stones, renal cancer, and prostate enlargement), growing patient preference for minimally invasive urological surgeries, and ongoing technological advancements in surgical laser products.

North America is expected to hold the largest share of the global Surgical Lasers Market, followed by Europe in 2016. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=12712582

Factors driving Surgical Lasers Market growth in the Asia-Pacific region include the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population), rising awareness among healthcare professionals related to the procedural benefits of surgical laser products, and increasing government initiatives to reduce the burden of ophthalmic disorders.

As of 2015, Lumenis (Israel), Cynosure, Inc. (U.S.), Alma Lasers (Israel), IPG Photonics Corporation (U.S.), Abbott Laboratories, Inc. (U.S.), Boston Scientific Corporation (U.S.), Spectranetics Corporation (U.S.), Biolitec AG (Austria), Fotona d.o.o. (Slovenia), and BISON MEDICAL Co., Ltd. (South Korea) are some of the key players operating in the Surgical Lasers Market.    

Veterinary Surgical Instruments Market - Global Forecast to 2021

The global veterinary surgical instruments market is estimated to reach USD 1,029.0 Million by 2021 from USD 748.4 Million in 2016, grow at a CAGR of 6.6% during the forecast period.

The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure.

In addition, the growth in the number of veterinary practitioners and the growth in the number of soft tissue injuries and trauma surgeries among pets are responsible for driving the overall growth of this market. The emerging regions such as Asia-Pacific offer an added potential due to the large livestock population in this region and the rising disposable incomes in this region.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=212886010

Years considered for this report

• 2015 – Base Year
• 2016 – Estimated Year
• 2021 – Projected Year

The major players in the global veterinary surgical instruments market are B. Braun Vet Care GmbH (Germany), Medtronic Plc.(Ireland), Ethicon Inc. (U.S.), JORGEN KRUSSE A/S (Denmark), Jorgensen Laboratories (U.S.), Smiths Group Plc (U.K.), Neogen Corporation (U.S.), Integra LifeSciences Holdings Corporation (U.S.), STERIS Corporation (U.S.), DRE Veterinary (U.S.), GerMedUSA, Inc. (U.S.), Surgical Holdings (U.K.), Sklar Surgical Instruments (U.S.), World Precision Instruments, Inc. (U.S.), Surgical Direct (U.S.), Antibe Therapeutics Inc. (Canada), and iM3 (U.S.).

Target Audience:

• Veterinary Surgical Instrument Manufacturers and Distributors
• Veterinary Hospitals and Clinics
• Veterinary Institutes
• Research Institutes
• Government Associations
• Research and Consulting Firms
• Animal Health Research & Development (R&D) Companies
• Contract Manufacturing Organizations (CMOs)

In 2015, North America dominated the veterinary surgical instruments market followed by Europe, Asia-pacific, and Rest of the World. Increasing number of companion animals, rising animal healthcare expenditure, increasing awareness about animal diseases, growing number of veterinary practitioners and their income levels, and growth in the pet insurance market are factors driving the growth of this market. On the other hand, the Asia-Pacific (APAC) region is expected to witness the highest growth rate during the forecast period. This can be mainly attributed to the rising livestock population, growing pet adoption, increasing awareness about animal health, progressive urbanization, and growing per capita animal health expenditure in this region.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/veterinary-surgical-instrument-market-212886010.html

Bowel Management Systems Market Trends and Industry Analysis Report 2018

Bowel Management Systems Market by Product (Irrigation Systems, Nerve Modulation Devices, Colostomy Bags, and Accessories), Patient Type (Adult and Pediatric), End User (Home Care and Hospitals, Ambulatory Surgery Center) - Global Forecast to 2023", published by MarketsandMarkets™

Global market is projected to reach USD 2.07 billion by 2023 from USD 1.74 billion in 2018, at a CAGR of 3.5% during the forecast period.

Browse 61 market data Tables and 31 Figures spread through 120 Pages and in-depth TOC on "Bowel Management Systems Market"

https://www.marketsandmarkets.com/Market-Reports/bowel-management-system-market-45043428.html

Early buyers will receive 10% customization on reports 

Growth in the Bowel Management Systems Market is mainly driven by factors such as the expanding target patient and growing geriatric population, availability of technologically advanced bowel management products, and favorable reimbursement scenario in developed countries.

The colostomy bags segment is expected to form the largest segment during the forecast period. 

Based on product, the Bowel Management Systems Market is categorized into four major segments, namely, irrigation systems, nerve modulation devices, colostomy bags, and other products & accessories. The colostomy bags segment is expected to account for the largest share in the Bowel Management Systems Market in 2018. Increasing number of target patient population, and growing availability of medical reimbursements for colostomy products across developed markets are expected to drive the growth of the colostomy bags segment in the next five years.

Adult patients segment is estimated to register the highest growth rate in the Bowel Management Systems Market during the forecast period 

The Bowel Management Systems Market is segmented, by patient type, into adult and pediatric patients. The adult patients segment is expected to register the highest growth rate in the Bowel Management Systems Market during the forecast period, owing to the factors such as the significant prevalence of FI among adults, increased public-private initiatives to enhance patient awareness related to effective FI management, and availability of advanced bowel management products.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=45043428

The home care segment is estimated to register the highest growth rate in the Bowel Management Systems Market during the forecast period 

The Bowel Management Systems Market is segmented, by end user, into home care and hospitals & ambulatory surgery centers. The home care segment is expected to register the highest growth rate of the Bowel Management Systems Market during the forecast period, owing to the factors such as the significant usage and growing adoption of bowel management products in home care settings, and need for device replacement on a regular basis.

In 2018, Europe accounted for the largest share of the bowel management systems market 

Geographically, the Bowel Management Systems Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of the market in 2018. The large share can be attributed to the significant disease (colorectal/bladder cancer & IBD) burden, favorable reimbursement scenario, and the increase in its geriatric population.

Some of the major players operating in the Bowel Management Systems Market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).

Know more about the Bowel Management Systems Market: 

https://www.marketsandmarkets.com/Market-Reports/bowel-management-system-market-45043428.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com